Our specialist knowledge and operational experience over more than 20 years enable us to deliver real-world evidence to improve understanding of treatment effectiveness and safety and guide better decision-making in healthcare.
Our work has supported applications to reimbursement authorities including the National Institute for Health and Care Excellence (NICE), All Wales Medicines Strategy Group (AWMSG), Scottish Medicines Consortium (SMC), and equivalent European regulatory bodies.
We have published more than 200 papers and abstracts in peer-reviewed journals, all of which can be viewed in our Publications section.
Our clients include Adelphi, Aimmune Therapeutics, Alexion, Alimera Sciences, Astellas, AstraZeneca, Diurnal, Eisai, Grunenthal, KRKA, MedImmune, Merck, Norgine, Novartis, Pfizer, Reckitt Benckiser, Sanofi-Aventis, Shionogi, Shire, Takeda and the NHS.
Site |
Badges |
|
Pharmatelligence
23-24 Wordsworth Avenue
Cardiff, , CF24 3FR
United Kingdom
|
|